We use cookies to ensure that we give you the best website experience. By continuing to use this site, you are agreeing to our use of cookies.

Close
Loading images...
  • For patients worldwide

    For patients worldwide

    Developing Innovative New Drugs Focusing on the Areas of Oncology, Nephrology and Immunology.

  • We bring innovative pharmaceuticals to the world

    We bring innovative pharmaceuticals to the world

    We are devoted to developing innovative antibody engineering technology by pursuing the truth of life more deeply.

  • "Therapeutic Antibodies" Hopes for the Future

    "Therapeutic Antibodies" Hopes for the Future

    We are devoted to developing innovative antibody engineering technology by pursuing the truth of life more deeply.

Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets.
Kyowa Kirin International is a subsidiary of Kyowa Kirin Co., Ltd. the Japan-based global specialty pharmaceutical company.

General Enquiries

Kyowa Kirin International
Galabank Business Park
Galashiels, TD1 1QH
United Kingdom
T +44 (0) 1896 664000

Media Enquiries

For media enquiries please contact:
Stacey Minton - Corporate Communications
Phone: +44 (0) 1896 664000
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Safety Information Europe

For concerns about the safety of any Kyowa Kirin International
products in Europe:
Telephone: +44 (0) 1896 664000
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Safety Information USA

For information on Kyowa Kirin International products in the USA:
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Business Development

For Business Development enquiries contact:
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Kyowa Kirin Ltd. (UK: New window opensEnglish)
  • Kyowa Kirin, Inc. (USA: New window opensEnglish)
  • Kyowa Kirin Farmacéutica S.L.U. (Spain: New window opensSpanish)
  • Kyowa Kirin Pharma S.A.S. (France: New window opensFrench)
  • Kyowa Kirin GmbH. (Germany: New window opensGerman)
  • Kyowa Kirin Sàrl (Switzerland: New window opensGerman)
  • Kyowa Kirin S.r.l. (Italy: New window opensItalian)
  • Kyowa Kirin Pharma B.V. (Netherlands: New window opensDutch)
  • Kyowa Kirin Pharma B.V. (Belgium + Luxembourg: New window opensEnglish)
  • Kyowa Kirin AB. (Sweden: New window opensSwedish)
  • Kyowa Kirin AB. (Finland: New window opensFinnish)
  • Kyowa Kirin AB. (Norway: New window opensNorwegian)
  • Kyowa Kirin AB. (Denmark: New window opensDanish)
  • Kyowa Kirin Pharma FZ-LLC. (UAE: New window opensEnglish)
  • Kyowa Kirin Farmacêutica, Unipessoal LDA. (Portugal: New window opensPortugese)
  • Kyowa Kirin Pharma s.r.o. (CEE: New window opensCzech)